Skip to content
value.today

Cingulate Inc.: insider trading

59 trades by 12 directors, officers and 10% owners since 2021, from their SEC Form 4 and 5 filings.

Bought, 12 months
$657 K
5 purchases by 5 insiders
Sold, 12 months
$0
0 sales by 0 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$657 K-$842$0Aug 2024: bought $0 (0 trades), sold $842 (1 trades)Aug 24Feb 2026: bought $657 K (5 trades), sold $0 (0 trades)Feb
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (12)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Cingulate Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Jennifer L. CallahanEVP and CFO13,961$25 K—
Matthew BramsEVP and Chief Medical Officer8,157$10 K—
Nilay Dahyabhai PatelEVP, CLO and CCO3,389——
Raul R. SilvaEVP and CSO4,645——
Shane J. SchafferChief Executive Officer, Director4,076$34 K—
Thomas Jeffrey HargrovesDirector8,300$490 K—
Peter J. WerthDirector—$98 K—
Laurie MyersEVP and COO0——
Craig S. GilgallonEVP, GC and Secretary9,550——
Gregg Wm GivensDirector154,318——
Curtis MedeirosDirector0——
Louis G. Van HornEVP and CFO15,000——

Trades#

Cingulate Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Laurie MyersEVP and COOSell-202$4.170$8420Form 4
filed Curtis MedeirosDirectorSell-17,532$1.270$22 K0Form 4